Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionEnsign Peak Advisors, Inc
Latest Disclosed Ownership445,903 shares
Latest Disclosed Value $ 25,911,423
Ensign Peak Advisors, Inc reports 15.50% decrease in ownership of PCVX / Vaxcyte, Inc.

On May 13, 2026 - Ensign Peak Advisors, Inc filed a 13F-HR form disclosing ownership of 445,903 shares of Vaxcyte, Inc. (US:PCVX) valued at $25,911,423 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 527,688 shares of Vaxcyte, Inc.. This represents a change in shares of -15.50% during the quarter. The current value of the position is $21,117,966 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F VAXCYTE COM 92243G108 445,903 -81,785 -15.50 25,911 6.42 0.0483
2026-02-12 2025-12-31 13F VAXCYTE COM 92243G108 527,688 -1,165 -0.22 24,348 27.81 0.0430
2025-11-13 2025-09-30 13F VAXCYTE COM 92243G108 528,853 -3,350 -0.63 19,049 10.10 0.0313
2025-08-12 2025-06-30 13F VAXCYTE COM 92243G108 532,203 -211,957 -28.48 17,302 -38.43 0.0296
2025-05-14 2025-03-31 13F VAXCYTE COM 92243G108 744,160 158,032 26.96 28,099 -41.44 0.0538
2025-02-14 2024-12-31 13F VAXCYTE COM 92243G108 586,128 39,293 7.19 47,980 -23.21 0.0853
2024-11-14 2024-09-30 13F VAXCYTE COM 92243G108 546,835 84,153 18.19 62,487 78.85 0.1099
2024-08-13 2024-06-30 13F VAXCYTE COM 92243G108 462,682 -13,018 -2.74 34,937 7.52 0.0638
2024-05-14 2024-03-31 13F VAXCYTE COM 92243G108 475,700 114,569 31.73 32,495 43.28 0.0593
2024-02-14 2023-12-31 13F VAXCYTE COM 92243G108 361,131 85,345 30.95 22,679 61.31 0.0449
2023-11-13 2023-09-30 13F VAXCYTE COM 92243G108 275,786 0 0.00 14,060 2.08 0.0300
2023-08-14 2023-06-30 13F VAXCYTE COM 92243G108 275,786 26,900 10.81 13,773 47.64 0.0279
2023-05-15 2023-03-31 13F VAXCYTE COM 92243G108 248,886 350 0.14 9,328 -21.73 0.0202
2023-02-13 2022-12-31 13F Vaxcyte COM 92243G108 248,536 144,961 139.96 11,917 379.36 0.0268
2022-11-14 2022-09-30 13F Vaxcyte COM 92243G108 103,575 28,665 38.27 2,486 52.52 0.0062
2022-08-12 2022-06-30 13F Vaxcyte COM 92243G108 74,910 39,010 108.66 1,630 88.00 0.0039
2022-05-16 2022-03-31 13F Vaxcyte COM 92243G108 35,900 34,480 2,428.17 867 2,450.00 0.0018
2022-02-11 2021-12-31 13F Vaxcyte COM 92243G108 1,420 1,420 34 0.0001
2021-08-13 2021-06-30 13F Vaxcyte COM 92243G108 0 -20,873 -100.00 0 -100.00
2021-05-12 2021-03-31 13F Vaxcyte COM 92243G108 20,873 0 0.00 412 -25.77 0.0009
2021-02-12 2020-12-31 13F Vaxcyte COM 92243G108 20,873 20,873 555 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.